Laureate Education And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – Laureate Education (LAUR), Erie Indemnity Company (ERIE), Ecolab (ECL) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Laureate Education (LAUR)

13.5% sales growth and 8.5% return on equity

Laureate Education, Inc., together with its subsidiaries, provides higher education programs and services to students through a network of universities and higher education institutions. It offers a range of undergraduate and graduate degree programs primarily in the areas of business and management, medicine and health sciences, and engineering and information technology through campus-based, online, and hybrid programs. The company provides its services in Brazil, Mexico, Chile, Peru, and the United States. The company was formerly known as Sylvan Learning Systems, Inc. and changed its name to Laureate Education, Inc. in May 2004. The company was founded in 1989 and is headquartered in Baltimore, Maryland.

Earnings Per Share

As for profitability, Laureate Education has a trailing twelve months EPS of $0.44.

PE Ratio

Laureate Education has a trailing twelve months price to earnings ratio of 28.55. Meaning, the purchaser of the share is investing $28.55 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.5%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 108% and 36.8%, respectively.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Laureate Education’s EBITDA is 395.28.

Sales Growth

Laureate Education’s sales growth is 13.4% for the present quarter and 13.5% for the next.

2. Erie Indemnity Company (ERIE)

9.9% sales growth and 22.42% return on equity

Erie Indemnity Company operates as a managing attorney-in-fact for the subscribers at the Erie Insurance Exchange in the United States. The company provides sales, underwriting, policy issuance, and renewal services for the policyholders on behalf of the Erie Insurance Exchange. It also offers sales related services, including agent compensation, and sales and advertising support services; and underwriting services comprise underwriting and policy processing; and other services consist of customer services and administrative support services, as well as information technology services. Erie Indemnity Company was incorporated in 1925 and is based in Erie, Pennsylvania.

Earnings Per Share

As for profitability, Erie Indemnity Company has a trailing twelve months EPS of $6.06.

PE Ratio

Erie Indemnity Company has a trailing twelve months price to earnings ratio of 34.36. Meaning, the purchaser of the share is investing $34.36 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.42%.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Jul 4, 2023, the estimated forward annual dividend rate is 4.76 and the estimated forward annual dividend yield is 2.3%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 12%, now sitting on 2.92B for the twelve trailing months.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 24.2% and 21.7%, respectively.

Volume

Today’s last reported volume for Erie Indemnity Company is 2259 which is 98.34% below its average volume of 136883.

3. Ecolab (ECL)

7.8% sales growth and 16.2% return on equity

Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences segments. The Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, metals and mining, power generation, pulp and paper, commercial laundry, petroleum, refining, and petrochemical industries. The Global Institutional & Specialty segment provides specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education, and retail industries. Its Global Healthcare & Life Sciences segment offers specialized cleaning and sanitizing products to the healthcare, personal care, and pharmaceutical industries, such as infection prevention and surgical solutions, and end-to-end cleaning and contamination control solutions under the Ecolab, Microtek, and Anios brand names. The company's Other segment offers pest elimination services to detect, eliminate, and prevent pests, such as rodents and insects in restaurants, food and beverage processors, educational and healthcare facilities, hotels, quick service restaurant and grocery operations, and other institutional and commercial customers. This segment also provides colloidal silica for binding and polishing applications in semiconductor, catalyst, and aerospace component manufacturing, as well as chemical industries; and products and services that manage wash process through custom designed programs, premium products, dispensing equipment, water and energy management, and reduction, as well as real time data management. It sells its products through field sales and corporate account personnel, distributors, and dealers. Ecolab Inc. was founded in 1923 and is headquartered in Saint Paul, Minnesota.

Earnings Per Share

As for profitability, Ecolab has a trailing twelve months EPS of $4.02.

PE Ratio

Ecolab has a trailing twelve months price to earnings ratio of 45.8. Meaning, the purchaser of the share is investing $45.8 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.2%.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Jun 15, 2023, the estimated forward annual dividend rate is 2.12 and the estimated forward annual dividend yield is 1.15%.

Moving Average

Ecolab’s worth is above its 50-day moving average of $179.93 and way higher than its 200-day moving average of $161.23.

4. Owens (OI)

6.8% sales growth and 47.84% return on equity

O-I Glass, Inc., through its subsidiaries, manufactures and sells glass containers to food and beverage manufacturers primarily in the Americas, Europe, and the Asia Pacific. It produces glass containers for alcoholic beverages, including beer, flavored malt beverages, spirits, and wine. The company is also involved in the production of glass packaging for various food items, soft drinks, tea, juices, and pharmaceuticals. It offers glass containers in a range of sizes, shapes, and colors. The company sells its products directly to customers under annual or multi-year supply agreements, as well as through distributors. O-I Glass, Inc. was founded in 1903 and is headquartered in Perrysburg, Ohio.

Earnings Per Share

As for profitability, Owens has a trailing twelve months EPS of $4.58.

PE Ratio

Owens has a trailing twelve months price to earnings ratio of 4.93. Meaning, the purchaser of the share is investing $4.93 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 47.84%.

5. Zoetis (ZTS)

5.8% sales growth and 45.21% return on equity

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides; vaccines; anti-infectives; other pharmaceutical products; dermatology; and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products and laboratory; and other non-pharmaceutical products. It markets its products to veterinarians, livestock producers, and pet owners. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Earnings Per Share

As for profitability, Zoetis has a trailing twelve months EPS of $4.41.

PE Ratio

Zoetis has a trailing twelve months price to earnings ratio of 42.89. Meaning, the purchaser of the share is investing $42.89 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 45.21%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Zoetis’s EBITDA is 102.25.

Yearly Top and Bottom Value

Zoetis’s stock is valued at $189.16 at 11:22 EST, below its 52-week high of $194.99 and way above its 52-week low of $124.15.

Leave a Reply

Your email address will not be published. Required fields are marked *